United States
Germany
Japan
United Kingdom
China
Recombinant protein of human mitogen-activated protein kinase 3 (MAPK3), transcript variant 1, 20 µg
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Products
Recombinant protein of human mitogen-activated protein kinase 3 (MAPK3), transcript variant 1, 100 µg
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Recombinant protein of human mitogen-activated protein kinase 3 (MAPK3), transcript variant 1, 1 mg
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
MAPK3 HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
MAPK3 HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Transient overexpression lysate of mitogen-activated protein kinase 3 (MAPK3), transcript variant 1
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Transient overexpression lysate of mitogen-activated protein kinase 3 (MAPK3), transcript variant 2
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
LY421885 is the same product as LY425672.
Transient overexpression lysate of mitogen-activated protein kinase 3 (MAPK3), transcript variant 3
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
MAPK3 HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
MAPK3 HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Transient overexpression of MAPK3, transcript variant 3, in HEK293T cells, FFPE control for IHC, ICC and ISH staining, 25 slides per pack
Transient overexpression of MAPK3, transcript variant 2, in HEK293T cells, FFPE control for IHC, ICC and ISH staining, 25 slides per pack
Transient overexpression of MAPK3, transcript variant 1, in HEK293T cells, FFPE control for IHC, ICC and ISH staining, 25 slides per pack
活动过滤器
优化搜索结果
Species
Brands
QC Levels
Pathways
- Acute myeloid leukemia (13)
- Adherens junction (13)
- Alzheimer's disease (13)
- Axon guidance (13)
- B cell receptor signaling pathway (13)
- Bladder cancer (13)
- Chemokine signaling pathway (13)
- Chronic myeloid leukemia (13)
- Colorectal cancer (13)
- Dorso-ventral axis formation (13)
- Endometrial cancer (13)
- ErbB signaling pathway (13)
- Fc epsilon RI signaling pathway (13)
- Fc gamma R-mediated phagocytosis (13)
- Focal adhesion (13)
- Gap junction (13)
- Glioma (13)
- GnRH signaling pathway (13)
- Insulin signaling pathway (13)
- Long-term depression (13)
- Long-term potentiation (13)
- MAPK signaling pathway (13)
- Melanogenesis (13)
- Melanoma (13)
- NOD-like receptor signaling pathway (13)
- Natural killer cell mediated cytotoxicity (13)
- Neurotrophin signaling pathway (13)
- Non-small cell lung cancer (13)
- Oocyte meiosis (13)
- Pancreatic cancer (13)
- Pathways in cancer (13)
- Prion diseases (13)
- Progesterone-mediated oocyte maturation (13)
- Prostate cancer (13)
- Regulation of actin cytoskeleton (13)
- Renal cell carcinoma (13)
- T cell receptor signaling pathway (13)
- TGF-beta signaling pathway (13)
- Thyroid cancer (13)
- Toll-like receptor signaling pathway (13)
- Type II diabetes mellitus (13)
- VEGF signaling pathway (13)
- Vascular smooth muscle contraction (13)
- mTOR signaling pathway (13)
